Is there any reason for licensed California medical professionals to be concerned with the aggressive stance taken by the state's Medical Board in targeting individuals for disciplinary actions?
Positive public relations hasn't exactly been a strong suit for California-based Wells Fargo the past couple years. Indeed, the bank has been under a withering spotlight for both allegations and proven charges focused on various types of consumer fraud.
The fiduciary standard applicable to investment advisers/brokers in California and nationally was a hot-button item in 2016. Implementing new rules to expand oversight duties and liabilities for financial professionals was a core objective of the Obama presidency during its final year.
It could be a client who earlier voiced approval with fee arrangements, yet is now disputing them via a formal complaint made to the California State Bar.
If you're a registered securities adviser/broker, you know what Finra is. In fact, you are likely regulated in all material aspects by that national not-for-profit entity, which sets policies and writes rules for most of the country's licensed financial professionals.
UCLA has closed its so-called "compounding" pharmacy following a state probe of its internal records and practices relative to specialty drugs made and delivered for patients' use at multiple university medical outlets.
California professionals across myriad industries typically have one thing in common.
Californian physicians were brought into the spotlight of the state Senate this year. A new house bill was proposed to renew the physician and nursing licensing board for another four years. While this is unanimously agreed upon, an addition to the bill has been contested. Under the proposed Senate Bill 798, a number of doctors on probation would be forced to disclose their status directly to patients.